Literature DB >> 9293952

Lactate transport in heart in relation to myocardial ischemia.

A P Halestrap1, X Wang, R C Poole, V N Jackson, N T Price.   

Abstract

In this article, the importance of lactic acid transport into and out of heart cells is described and the properties of the monocarboxylate transporters (MCTs) responsible are presented. These are monocarboxylate/proton symporters with a broad substrate specificity that includes L-lactate, pyruvate, and the ketone bodies acetate, acetoacetate, and beta-hydroxybutyrate. Although it is unlikely that lactic acid transport constrains heart metabolism under most conditions, it may do so during severe hypoxia or ischemia. The transporter plays a critical role in maintaining intracellular pH because it removes the protons that are produced stoichiometrically with lactate during glycolysis. The kinetics and substrate and inhibitor specificities of the transport process have been determined in cell suspensions using a radiotracer technique and in single cells using a fluorescent measurement of the decrease in intracellular pH that accompanies transport. The results of these experiments suggest the presence of 2 different transporter isoforms in heart cells, at least one of which is different from the cloned MCT1 and MCT2. Immunofluorescence microscopy shows that MCT1 expression is restricted to the intercalated disk region, yet the rate of lactate transport in this region is slower than in the center of the cell, where there is no MCT1. New cDNA sequences with strong homology to MCT1 have been found in human cDNA libraries and Northern blots show that the corresponding mRNA is expressed in rat heart. Expressions of these new MCT isoforms have yet to be demonstrated and their properties and cellular distribution defined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293952     DOI: 10.1016/s0002-9149(97)00454-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Lactic acid: New roles in a new millennium.

Authors:  L B Gladden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

Authors:  P Kirk; M C Wilson; C Heddle; M H Brown; A N Barclay; A P Halestrap
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

3.  In vitro Models of Ischemia-Reperfusion Injury.

Authors:  Timothy Chen; Gordana Vunjak-Novakovic
Journal:  Regen Eng Transl Med       Date:  2018-05-10

Review 4.  Lactate transport in skeletal muscle - role and regulation of the monocarboxylate transporter.

Authors:  C Juel; A P Halestrap
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

Review 5.  Targeting gut microbiota as a possible therapy for mastitis.

Authors:  Xiaoyu Hu; Shumin Li; Yunhe Fu; Naisheng Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-11       Impact factor: 3.267

6.  The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.

Authors:  Matthew J Ovens; Christine Manoharan; Marieangela C Wilson; Clarey M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

Review 7.  Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.

Authors:  Mingming Sun; Wei Wu; Zhanju Liu; Yingzi Cong
Journal:  J Gastroenterol       Date:  2016-07-23       Impact factor: 7.527

8.  Cariporide enhances lactate clearance upon reperfusion but does not alter lactate accumulation during global ischaemia.

Authors:  H Lin; M-S Suleiman
Journal:  Pflugers Arch       Date:  2003-07-16       Impact factor: 3.657

9.  Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenase.

Authors:  Alexander B Kotlyar; Antonio Randazzo; Norman Honbo; Zhu-Qui Jin; Joel S Karliner; Gary Cecchini
Journal:  FEBS Lett       Date:  2010-01-04       Impact factor: 4.124

10.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

Authors:  Matthew J Ovens; Andrew J Davies; Marieangela C Wilson; Clare M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.